|1||A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed hodgkin disease and non-hodgkin lymphoma.
文獻出處：Bio Blood Marrow Transplant. 11; 181-187 (2005)
|2||Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.
文獻出處：Br J cancer. 81; 1000-1016 (1999)